Studies by scientists in Iceland and Australia have suggested that genetics, rather than skin tone, may be a better indicator for who is most at risk from skin cancer.
Iceland-based deCODE Genetics is amongst the groups which have identified a gene called ASIP that doubles the risk of getting melanoma, along with the already-identified gene MC1R that has a similar effect. Both genes are linked to red hair, freckles and sun sensitivity, so explaining the traditionally-accepted link, the New Scientist magazine reported.
Kari Stefannson, chief executive of deCODE, stressed that the gene had little effect in his native country where strong sunlight is rare, and so the key factor in avoiding melanoma was still staying out of direct sunlight.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze